6,776 Shares in Marsh & McLennan Companies, Inc. $MRSH Bought by Smith Salley Wealth Management

Smith Salley Wealth Management bought a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the first quarter, Holdings Channel reports. The fund bought 6,776 shares of the financial services provider’s stock, valued at approximately $1,175,000.

Other institutional investors have also modified their holdings of the company. Procyon Advisors LLC lifted its holdings in shares of Marsh & McLennan Companies by 2.5% in the 4th quarter. Procyon Advisors LLC now owns 2,279 shares of the financial services provider’s stock valued at $423,000 after buying an additional 56 shares during the period. PFG Investments LLC raised its position in Marsh & McLennan Companies by 3.3% during the fourth quarter. PFG Investments LLC now owns 1,758 shares of the financial services provider’s stock valued at $326,000 after acquiring an additional 56 shares in the last quarter. Lindenwold Advisors INC lifted its holdings in Marsh & McLennan Companies by 0.4% in the third quarter. Lindenwold Advisors INC now owns 14,994 shares of the financial services provider’s stock valued at $3,022,000 after acquiring an additional 62 shares during the period. SeaCrest Wealth Management LLC boosted its position in Marsh & McLennan Companies by 3.9% in the 4th quarter. SeaCrest Wealth Management LLC now owns 1,673 shares of the financial services provider’s stock worth $306,000 after purchasing an additional 63 shares in the last quarter. Finally, First Heartland Consultants Inc. grew its stake in shares of Marsh & McLennan Companies by 7.1% during the 3rd quarter. First Heartland Consultants Inc. now owns 1,000 shares of the financial services provider’s stock worth $202,000 after purchasing an additional 66 shares during the period. Hedge funds and other institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Price Performance

Shares of NYSE MRSH opened at $160.23 on Tuesday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28. The firm has a market capitalization of $77.41 billion, a P/E ratio of 20.03, a P/E/G ratio of 2.37 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a one year low of $156.60 and a one year high of $220.32.

Marsh & McLennan Companies (NYSE:MRSH) last announced its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.21 by $0.08. The business had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, equities research analysts forecast that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on MRSH shares. UBS Group decreased their target price on shares of Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating for the company in a research note on Tuesday, June 9th. Barclays cut their price objective on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. Mizuho decreased their price objective on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research report on Monday, April 13th. Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price on the stock in a research report on Wednesday, May 6th. Finally, Morgan Stanley cut their price target on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research note on Monday, April 6th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $200.19.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.